[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
September 18, 1996

Small, Dense Low-Density Lipoprotein Particles and Coronary Heart Disease RiskA Clear Association With Uncertain Implications

Author Affiliations

From the Departments of Epidemiology and Medicine and the Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, Md.

JAMA. 1996;276(11):914-915. doi:10.1001/jama.1996.03540110068034
Abstract

Two articles in this issue of The Journal1,2 examine prospectively whether smaller low-density lipoprotein (LDL) particle size predicts coronary heart disease (CHD) incidence. The heterogeneity of LDL particles with respect to size, density, and composition is well recognized. A predominance of small LDL particles in the plasma is often accompanied by hepatic overproduction of very low-density lipoproteins (VLDLs) and hypertriglyceridemia. Exchange of triglycerides from the VLDL core with cholesteryl esters from the LDL core and subsequent hydrolysis of the triglycerides result in smaller LDL particles. These smaller LDL particles are denser since they still contain the same amount of protein (apolipoprotein B [apo B]) as other LDL particles but a smaller amount of lipids, which are more buoyant. Thus, the LDL apo B level measures the number of LDL particles, while LDL cholesterol (LDL-C) is a measure which combines the number of particles and their cholesterol content.

See also

References
1.
Stampfer MJ, Krauss RM, Ma J, et al.  A prospective study of triglycerides, LDL particle diameter, and risk of myocardial infarction . JAMA . 1996;276:882-888.Article
2.
Gardner CD, Fortmann SP, Krauss RM.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women . JAMA . 1996;276:875-881.Article
3.
Austin MA.  Small, dense low-density lipoprotein as a risk factor for coronary heart disease . Int J Clin Lab Res . 1994;24:187-192.Article
4.
Roheim PS, Asztalos BF.  Clinical significance of lipoprotein size and risk for coronary atherosclerosis . Clin Chem . 1995;41:147-152.
5.
Coresh J, Kwiterovich PO, Smith HH, Bachorik PS.  Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women . J Lipid Res . 1993;34:1687-1697.
6.
Sharrett AR, Patsch W, Sorlie PD, et al.  Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease . Arterioscler Thromb . 1994;14:1098-1104.Article
7.
Austin MA, Hokanson JE, Brunzell JD.  Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance . Curr Opin Lipidol . 1994;5:395-403.Article
8.
Kwiterovich PO Jr.  Genetic and molecular biology of familial combined hyperlipidemia . Curr Opin Lipidol . 1993;4:133-143.Article
9.
Rotter JI, Xiangdon B, Cantor RM, et al.  Multilocus genetic determinants of LDL particle size in coronary artery disease families . Am J Hum Genet . 1996;58:585-594.
10.
Deeb SS, Yang WS, Nevin D, et al.  Mutations in the lipoprotein lipase gene in familial combined hyperlipidemia and coronary artery disease . Circulation . 1995;92:1-493.Article
11.
Gehrisch S, Tesche R, Kostka H, Julius U, Jaross W.  Point mutations in the hepatic triglyceride lipase (HTGL) gene in familial combined hyperlipidemia . Circulation . 1995;92:1-493.Article
×